Botanical polysaccharides: macrophage immunomodulation and therapeutic potential

IA Schepetkin, MT Quinn - International immunopharmacology, 2006 - Elsevier
Botanical polysaccharides exhibit a number of beneficial therapeutic properties, and it is
thought that the mechanisms involved in these effects are due to the modulation of innate …

The fetal inflammatory response syndrome

F Gotsch, R Romero, JP Kusanovic… - Clinical obstetrics and …, 2007 - journals.lww.com
The fetal inflammatory response syndrome (FIRS) is a condition characterized by systemic
inflammation and an elevation of fetal plasma interleukin-6. This syndrome has been …

Mesenchymal stem cells reduce inflammation while enhancing bacterial clearance and improving survival in sepsis

SHJ Mei, JJ Haitsma, CC Dos Santos… - American journal of …, 2010 - atsjournals.org
Rationale: Sepsis refers to the clinical syndrome of severe systemic inflammation
precipitated by infection. Despite appropriate antimicrobial therapy, sepsis-related morbidity …

Mrp8 and Mrp14 are endogenous activators of Toll-like receptor 4, promoting lethal, endotoxin-induced shock

T Vogl, K Tenbrock, S Ludwig, N Leukert, C Ehrhardt… - Nature medicine, 2007 - nature.com
To identify new components that regulate the inflammatory cascade during sepsis, we
characterized the functions of myeloid-related protein-8 (Mrp8, S100A8) and myeloid-related …

[HTML][HTML] Towards a unifying, systems biology understanding of large-scale cellular death and destruction caused by poorly liganded iron: Parkinson's, Huntington's …

DB Kell - Archives of toxicology, 2010 - Springer
Exposure to a variety of toxins and/or infectious agents leads to disease, degeneration and
death, often characterised by circumstances in which cells or tissues do not merely die and …

A soluble form of the triggering receptor expressed on myeloid cells-1 modulates the inflammatory response in murine sepsis

S Gibot, MN Kolopp-Sarda, MC Béné… - The Journal of …, 2004 - rupress.org
The triggering receptor expressed on myeloid cells (TREM)-1 is a recently discovered
receptor expressed on the surface of neutrophils and a subset of monocytes. Engagement of …

[HTML][HTML] Macrophage migration inhibitory factor (MIF): a promising biomarker

G Grieb, M Merk, J Bernhagen… - Drug news & …, 2010 - ncbi.nlm.nih.gov
Macrophage migration inhibitory (MIF) factor is an immunoregulatory cytokine whose effect
on arresting random immune cell movement was recognized several decades ago. Despite …

The D-dopachrome tautomerase (DDT) gene product is a cytokine and functional homolog of macrophage migration inhibitory factor (MIF)

M Merk, S Zierow, L Leng, R Das… - Proceedings of the …, 2011 - National Acad Sciences
Macrophage migration inhibitory factor (MIF) is a pivotal regulator of the immune response.
Neutralization or genetic deletion of MIF does not completely abrogate activation responses …

The macrophage migration inhibitory factor-glucocorticoid dyad: regulation of inflammation and immunity

H Flaster, J Bernhagen, T Calandra… - Molecular …, 2007 - academic.oup.com
The cytokine macrophage migration inhibitory factor (MIF) occupies a unique position in
physiology by its ability to directly regulate the immunosuppressive actions of …

Mechanisms of disease: mechanisms and clinical implications of cholestasis in sepsis

A Geier, P Fickert, M Trauner - Nature clinical practice Gastroenterology …, 2006 - nature.com
Cholestasis is a common complication in patients with extrahepatic bacterial infection and
sepsis. This article gives a comprehensive overview of the molecular and cellular …